TITLE

Pulmonary hypertension: NO therapy?

AUTHOR(S)
Adnot, S.; Raffestin, B.
PUB. DATE
July 1996
SOURCE
Thorax;Jul1996, Vol. 51 Issue 7, p762
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66112718

 

Related Articles

  • The 2011 Grover Conference: Risk Factors in Pulmonary Hypertension: Gender, Sex Hormones, Obesity, Novel Genetic Influences and Risk Factors Sedalia, Colorado, USA 7-11 September, 2011.  // Pulmonary Circulation;2011, Vol. 1 Issue 4, pS1 

    The article presents abstracts on medical topics which include apelin and pulmonary hypertension, the role of medical therapy in non-PAH pulmonary hypertension, and the influence of serotonin and estrogen in the development of pulmonary arterial hypertension.

  • Guest Editor's Memo. White, R. James // Advances in Pulmonary Hypertension;Spring2012, Vol. 11 Issue 1, p2 

    An introduction is presented in which the editor discusses various reports within the issue on topics including pulmonary hypertension, combination therapy and warfarin for treating pulmonary hypertension.

  • Therapy.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 3, p94 

    The article presents abstracts on medical topics including the impact of pulmonary arterial hypertension management by first-line sildenafil monotreatment, the safety of epoprostenol therapy in pulmonary capillary disease and the treatment of pulmonary hypertension through ambrisentan therapy.

  • Beta-blocker therapy in an infant with pulmonary hypertension. Buchhorn, R.; Hulpke-Wette, M.; Wessel, A.; B├╝rsch, J. // European Journal of Pediatrics;1999, Vol. 158 Issue 12, p1007 

    Discusses the use of beta-blocker therapy in an infant with pulmonary hypertension. Description of primary pulmonary hypertension; Hemodynamic and neurohormonal data of the patient; Effectiveness of the beta-blocker therapy in protecting the myocardium against toxic norepinephrine levels.

  • Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy. Chaudhari, M.; Vogel, M.; Wright, C.; Smith, J.; Haworth, S. G. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Nov2005, Vol. 90 Issue 6, pF527 

    We report a case of severe pulmonary hypertension in a neonate associated with impaired alveolarisation and plexiform pulmonary arteriopathy. Treatment with oral sildenafil in addition to inhaled nitric oxide (NO) resulted in recovery from the pulmonary hypertensive crisis. Long term sildenafil...

  • Bosentan for Early Pulmonary Hypertension. Crawford, Michael H. // Clinical Cardiology Alert;Aug2008, Vol. 27 Issue 8, p66 

    The article discusses a study on the bosentan therapy for early pulmonary hypertension. The effect of bosentan therapy was compared to that of the placebo therapy which resulted to a conclusion that bosentan therapy is beneficial for patients with advanced symptoms due to pulmonary hypertension....

  • 851 Echo-guided inhaled prostacyclin therapy in primary pulmonary hypertension. Karlocai, K. // European Journal of Echocardiography;2003, Vol. 4 Issue suppl_1, pS105 

    An abstract of the article "Echo-guided inhaled prostacyclin therapy in primary pulmonary hypertension" by K. Karlocai is presented.

  • Prostacyclin and Primary Pulmonary Hypertension. Rich, Stuart // Annals of Internal Medicine;9/15/94, Vol. 121 Issue 6, p463 

    Editorial. Offers observations on the use of prostacyclin in patients with primary pulmonary hypertension. Limitations of prostacyclin; Views on research on the therapy.

  • Bosentan Therapy for Pulmonary Arterial Hypertension.  // New England Journal of Medicine;4/18/2002, Vol. 346 Issue 16, p1258 

    A correction to the article "Bosentan Therapy for Pulmonary Arterial Hypertension," that was published in the March 21, 2002 issue is presented.

  • Bosentan for Pulmonary Hypertension. Pereira, Brett N.; Salvi, Sundeep // New England Journal of Medicine;7/25/2002, Vol. 347 Issue 4, p292 

    A letter to the editor is presented in response to an article about bosentan therapy for pulmonary arterial hypertension in the March 21, 2002 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics